Mitochondrial accumulation of APP and Abeta: significance for Alzheimer disease pathogenesis.
Accumulating evidence suggest that alterations in energy metabolism are among the earliest events that occur in the Alzheimer disease (AD) affected brain. Energy consumption is drastically decreased in the AD-affected regions of cerebral cortex and hippocampus pointing towards compromised mitochondrial function of neurons within specific brain regions. This is accompanied by an elevated production of reactive oxygen species contributing to increased rates of neuronal loss in the AD-affected brain regions. In this review, we will discuss the role of mitochondrial function and dysfunction in AD. We will focus on the consequences of amyloid precursor protein and amyloid-beta peptide accumulation in mitochondria and their involvement in AD pathogenesis.
Pavlov
Pavel F
PF
Karolinska Institutet Dainippon Sumitomo Pharma Alzheimer Center, NVS, Novum, Huddinge, Sweden.
Hansson Petersen
Camilla
C
Glaser
Elzbieta
E
Ankarcrona
Maria
M
D000375:Aging / Q000473:pathology; D000544:Alzheimer Disease / Q000209:etiology* / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism* / Q000633:toxicity; D000818:Animals; D001921:Brain / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008928:Mitochondria / Q000378:metabolism*; D009928:Organ Specificity
D016564:Amyloid beta-Protein Precursor